Concepedia

Kashmira Shah

KS

20

Publications

1.3K

Citations

16

H-Index

1996

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Kashmira Shah is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1996–2020

20

Publications

20

11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice

Anne Hermanowski‐Vosatka, James M. Balkovec, Kang Cheng et al. · The Journal of Experimental Medicine · 2005 · 362 citations · Full text

Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo

G C Koo, Joseph T. Blake, Althea Talento et al. · The Journal of Immunology · 1997 · 217 citations · Full text

Cloning of a Cysteine Protease Required for the Molting of Onchocerca volvulus Third Stage Larvae

Sara Lustigman, James H. McKerrow, Kashmira Shah et al. · Journal of Biological Chemistry · 1996 · 96 citations · Full text

, , +16

Correolide and Derivatives Are Novel Immunosuppressants Blocking the Lymphocyte Kv1.3 Potassium Channels

Gloria C. Koo, Joseph T. Blake, Kashmira Shah et al. · Cellular Immunology · 1999 · 81 citations

, , +11

Identification and validation of genes affecting aortic lesions in mice

Xia Yang, Larry L. Peterson, Rolf Thieringer et al. · Journal of Clinical Investigation · 2010 · 57 citations · Full text

, , +24

Rows per page

1–5 of 20